External Source

Cll: Clinical Data For Rituximab/venetoclax

2018 3:43
Synopsis
Danielle Brander, MD, discusses the clinical data surrounding adding rituximab to venetoclax for patients with relapsed chronic ...

You Might Also Like

Venetoclax + Rituximab in Relapsed CLL 6:42
Venetoclax + Rituximab In Relapsed Cll
2019
The Role of Venetoclax + Rituximab in CLL 7:10
The Role Of Venetoclax + Rituximab In Cll
2020
Venetoclax Plus Rituximab in Relapsed/Refractory CLL 8:58
Venetoclax Plus Rituximab In Relapsed/refractory Cll
2019
Venetoclax/Rituximab Combo for Chronic Lymphocytic Leukemia Shows Reduced Disease Progression 3:56
Venetoclax/rituximab Combo For Chronic Lymphocytic Leukemia ...
2019
Venetoclax plus rituximab or obinutuzumab in CLL after alloHCT 2:00
Venetoclax Plus Rituximab Or Obinutuzumab In Cll After Alloh...
2019
Venetoclax + rituximab for R/R CLL: 7-year results of the MURANO trial 2:13
Venetoclax + Rituximab For R/r Cll: 7-year Results Of The Mu...
2023
Update from MURANO trial: venetoclax-rituximab leads to slower clonal growth rate in CLL 2:25
Update From Murano Trial: Venetoclax-rituximab Leads To Slow...
2022
Follow-Up Shows Venetoclax Plus Rituximab has Long-Term Efficacy in CLL 1:36
Follow-up Shows Venetoclax Plus Rituximab Has Long-term Effi...
2020
Venetoclax and rituximab: changing the treatment landscape in R/R CLL 5:17
Venetoclax And Rituximab: Changing The Treatment Landscape I...
2018
Venetoclax With Rituximab & Other Options After Relapse 4:23
Venetoclax With Rituximab & Other Options After Relapse
2019
Venetoclax/rituximab prolongs PFS in relapsed/refractory CLL 4:07
Venetoclax/rituximab Prolongs Pfs In Relapsed/refractory Cll
2018
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.